Innovative Technology INOVIO's focus on DNA medicine and novel immunotherapy technologies presents opportunities for partners specializing in advanced biotech tools, laboratory automation, and clinical trial support, aligning with their cutting-edge research initiatives.
Funding Momentum Recent public offering of $30 million and ongoing funding efforts highlight growth potential, making INOVIO an appealing prospect for investors and technology vendors seeking to support biotech innovation and expansion.
Strategic Industry Engagement Active participation in high-profile conferences like World Vaccine Congress and AACR indicates openness to collaborations and strategic partnerships with organizations advancing vaccine and cancer therapies.
Market Focus Specializing in HPV-related diseases, cancer, and infectious illnesses, INOVIO offers sales opportunities for diagnostic, clinical research, and biotech manufacturing solutions tailored to the immunotherapy and vaccine development sectors.
Talent and Infrastructure With a dedicated team of up to 500 employees and a modern tech stack, INOVIO is positioned for further expansion, creating potential for partnerships in cloud computing, data management, and laboratory infrastructure support.
INOVIO Pharmaceuticals, Inc. uses 8 technology products and services including SOLIDWORKS, Ansible, Kubernetes, and more. Explore INOVIO Pharmaceuticals, Inc.'s tech stack below.
| INOVIO Pharmaceuticals, Inc. Email Formats | Percentage |
| First.Last@inovio.com | 64% |
| FLast@inovio.com | 29% |
| Last@inovio.com | 5% |
| FirstLast@inovio.com | 2% |
Biotechnology ResearchPennsylvania, United States201-500 Employees
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world. For more information, visit www.inovio.com.
Company Overview
Media & News
Funding & FinancialsINOVIO Pharmaceuticals, Inc. has raised a total of $25M of funding over 15 rounds. Their latest funding round was raised on Jul 03, 2025 in the amount of $25M.
INOVIO Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M
Funding & FinancialsINOVIO Pharmaceuticals, Inc. has raised a total of $25M of funding over 15 rounds. Their latest funding round was raised on Jul 03, 2025 in the amount of $25M.
INOVIO Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com